Process for specific determination of cholesterol in the presence of the
HDL fraction in serum
    1.
    发明授权
    Process for specific determination of cholesterol in the presence of the HDL fraction in serum 失效
    在血清中HDL级分存在下特异性测定胆固醇的方法

    公开(公告)号:US4544630A

    公开(公告)日:1985-10-01

    申请号:US468792

    申请日:1983-02-22

    CPC分类号: C12Q1/60

    摘要: The present invention provides a process for the specific determination of the cholesterol of the LDL fraction in the presence of the HDL fraction of the lipoproteins of serum by the action of cholesterol esterase for the liberation of the cholesterol and oxidation of the liberated cholesterol with cholesterol oxidase and oxygen with the formation of hydrogen peroxide and cholestenone and kinetic measurement of the change of one of the reaction components of the oxidase reaction, especially the formation of hydrogen peroxide, wherein the measurement is carried out in a predetermined period of time, the reaction solution having a tenside concentration of 0.01 to 1.5 mmol/liter, a cholesterol esterase concentration of 0.1 to 30 U/ml. and a pH value of 6.5 to 8.0.The present invention also provides a reagent for carrying out this process.

    摘要翻译: 本发明提供了一种在胆固醇酯酶的作用下,通过胆固醇释放和胆固醇氧化酶氧化释放的胆固醇,在血清脂蛋白的HDL部分存在下,特异性测定LDL级分的胆固醇的方法 和氧气,形成过氧化氢和胆甾烯酮,动力学测量氧化酶反应的一种反应成分的变化,特别是过氧化氢的形成,其中测量在预定时间内进行,反应溶液 其表面活性剂浓度为0.01〜1.5mmol / l,胆固醇酯酶浓度为0.1〜30U / ml。 pH值为6.5〜8.0。 本发明还提供了一种用于进行该方法的试剂。

    Process for photometric determination of protein C and/or protein S
    7.
    发明授权
    Process for photometric determination of protein C and/or protein S 失效
    蛋白C和/或蛋白S的光度测定方法

    公开(公告)号:US5001069A

    公开(公告)日:1991-03-19

    申请号:US256100

    申请日:1988-10-04

    摘要: The present invention provides a process for the photometric determination of protein C and/or protein S activity, especially in plasma, wherein the sample containing the protein C and/or protein S to be determined is incubated with a protein C activator from snake venom with the formation of activated protein C and/or protein S and the decrease of the formation of thrombin from prothrombin brought about by the coagulation factors and the activators thereof is determined by means of a chromogenic thrombin substrate.

    摘要翻译: 本发明提供了一种用于光度测定蛋白C和/或蛋白S活性的方法,特别是在血浆中,其中将待测定的含有蛋白C和/或蛋白S的样品与来自蛇毒的蛋白C激活剂一起温育, 活化蛋白C和/或蛋白S的形成以及由凝血因子及其活化剂引起的凝血酶原形成的凝血酶的形成减少是通过显色凝血酶底物来确定的。